# US 2012/0252067 A1 · Systems for the Expression of Orthogonal Translation Components in Eubacterial Host Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252067 A1
- Document ID: US20120252067A1
- Status: Published application
- Kind: A1
- Application number: 13/468,736
- Filed: 2012-05-10
- Published: 2012-10-04
- Earliest claimed: 2006-03-09
- Assignees: The Scripps Research Institute
- Inventors: Youngha Ryu; Peter G. Schultz
- Web page: https://patentgrep.com/patent/US20120252067A1

## CPC

- C07K 14/245: Escherichia (G)
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The invention related to compositions and methods for the in vivo production of polypeptides comprising one or more unnatural amino acids. Specifically, the invention provides plasmid systems for the efficient eubacterial expression of polypeptides comprising one or more unnatural acids at genetically-programmed positions.

## Claims

### Claim at position 1

-44. (canceled)

### Claim 45

A method for producing, in a host cell, a polypeptide of interest comprising an unnatural amino acid at a specified position, the method comprising:
(a) providing:
(i) an unnatural amino acid;
(ii) a nucleic acid construct comprising a nucleotide sequence encoding an orthogonal tRNA (O-tRNA) and a nucleotide sequence encoding an orthogonal aminoacyl-tRNA synthetase (O-RS), wherein said O-RS preferentially aminoacylates said O-tRNA with said unnatural amino acid; and,
(iii) a polynucleotide encoding said polypeptide of interest, said polynucleotide comprising at least one selector codon that is recognized by said O-tRNA, and wherein the position of the selector codon correlates to the specified position of the unnatural amino acid in the polypeptide of interest;
(iv) a host cell comprising (i), (ii) and (iii); and
(b) growing said host cell; and
(c) incorporating said unnatural amino acid at said specified position in said polypeptide during translation of said polypeptide in said host cell, thereby producing said polypeptide of interest comprising said unnatural amino acid at the specified position.

### Claim 46 (depends on 45)

The method of claim 45, wherein:
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-tRNA derived from one or more Archaea tRNA; or
said providing a nucleic acid construct comprises providing a polycistronic operon comprising a plurality of nucleotide sequences encoding one or more O-tRNA species; or
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-tRNA comprising a nucleotide sequence of SEQ ID NO: 1 (MjtRNA-Tyr(CUA)); or
said providing a nucleic acid construct comprises providing a polycistronic operon comprising a plurality of the nucleotide sequence of SEQ ID NO: 1 (MjtRNA-Tyr(CUA)).

### Claim at position 4

47-49. (canceled)

### Claim 50 (depends on 45)

The method of claim 45, wherein:
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-RS derived from a Methanococcus jannaschii aminoacyl-tRNA synthetase; or
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-RS derived from a Methanococcus jannaschii tyrosyl-tRNA synthetase; or
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-RS having aspartic acid to arginine substitution at amino acid position 286 or at a position analogous to position 286, relative to the amino acid sequence of wild-type Methanococcus jannaschii tyrosyl-tRNA synthetase provided in SEQ ID NO: 2 (wild type Mj-tRNATyrRS).

### Claim at position 6

51-52. (canceled)

### Claim 53 (depends on 45)

The method of claim 45, wherein said providing a nucleic acid construct comprises providing at least one of:
(I) promoter and terminator nucleotide sequences derived from an Escherichia coli proline tRNA gene, wherein said promoter and terminator sequences are both operatively linked to said nucleotide sequence encoding said O-tRNA, and wherein said nucleotide sequence encoding said O-tRNA is heterologous to said promoter and terminator sequences;
(II) a promoter nucleotide sequence corresponding to a modified E. coli glnS promoter having a nucleotide sequence of SEQ ID NO: 13, wherein said modified E. coli glnS nucleotide sequence is operatively linked to said nucleotide sequence encoding said O-RS; and
(III) a polycistronic operon comprising a plurality of O-tRNA gene nucleotide sequences, wherein at least one O-tRNA gene is separated from at least one adjacent O-tRNA gene by a heterologous polynucleotide linker derived from a naturally occurring polynucleotide linker from a naturally occurring tRNA operon.

### Claim 54 (depends on 53)

The method of claim 53, wherein:
said providing a nucleic acid construct of (I) comprises providing nucleotide sequences corresponding to an Escherichia coli proline tRNA promoter and terminator sequences, said E. coli proline tRNA selected from E. coli proK, proL and proM tRNA; or
said providing a nucleic acid construct of (I) comprises providing nucleotide sequences corresponding to an Escherichia coli proline tRNA promoter and terminator sequences, said E. coli proline tRNA promoter and terminator sequences comprising the promoter and terminator sequences of E. coli proK provided in SEQ ID NOS: 32 (promoter) and 33 (terminator), respectively.

### Claim 55

(canceled)

### Claim 56 (depends on 53)

The method of claim 53, wherein:
said providing a polycistronic operon of (III) comprises providing a plurality of identical heterologous polynucleotide linkers; or
said providing a polycistronic operon of (III) comprises providing a plurality of heterologous polynucleotide linkers, wherein at least two of the heterologous polynucleotide linkers are different; or
said providing a polycistronic operon of (III) comprises providing a heterologous polynucleotide linker comprising a 5′ terminal thymidine nucleotide, a 3′ terminal adenosine nucleotide, or both a 5′ terminal thymidine nucleotide and a 3′ terminal adenosine nucleotide; or
said providing a polycistronic operon of (III) comprises providing a heterologous polynucleotide linker derived from the naturally occurring polynucleotide linker located between the endogenous Escherichia coli tRNA genes selected from: valU and valX; ileT and alaT; serV and argV; valV and valW; glyT and thrT; metT and leuW; glnW and metU; hisR and leuT; glnU and glnW; leuP and leuV; glnV and glnX; alaW and alaX; ileU and alaU; ileV and alaV; metU and glnV; glyW and cysT; argX and hisR; and argY and argZ; or
said providing a polycistronic operon of (III) comprises providing a heterologous polynucleotide linker derived from the nucleotide sequence of SEQ ID NO: 14 (valU/valX linker) or 15 (ileT/alaT linker).

### Claim at position 11

57-60. (canceled)

### Claim 61 (depends on 45)

The method of claim 45, wherein:
said providing a host cell comprises providing a eubacterial host cell; or
said providing a host cell comprises providing an Escherichia coli host cell.

### Claim 62

(canceled)

### Claim 63

A method for producing in a host cell a polypeptide of interest comprising an unnatural amino acid at a specified position, the method comprising:
(a) providing:
(i) an unnatural amino acid;
(ii) a nucleic acid construct comprising a nucleotide sequence encoding an orthogonal tRNA (O-tRNA);
(iii) a nucleic acid construct comprising a nucleotide sequence encoding an orthogonal aminoacyl-tRNA synthetase (O-RS), wherein said O-RS preferentially aminoacylates said O-tRNA with said unnatural amino acid;
(iv) a polynucleotide encoding said polypeptide of interest, said polynucleotide comprising at least one selector codon that is recognized by said O-tRNA, and wherein the position of the selector codon correlates to the specified position of the unnatural amino acid in the polypeptide of interest; and,
(v) a host cell comprising (i), (ii), (iii) and (iv);
wherein said nucleic acid constructs of (ii) and (iii) collectively comprise at least one of:
(I) promoter and terminator nucleotide sequences derived from an Escherichia coli proline tRNA gene, wherein said promoter and terminator sequences are both operatively linked to said nucleotide sequence encoding said O-tRNA, and wherein said nucleotide sequence encoding said O-tRNA is heterologous to said promoter and terminator sequences;
(II) a promoter nucleotide sequence corresponding to a modified E. coli glnS promoter having a nucleotide sequence of SEQ ID NO: 13, wherein said modified E. coli glnS nucleotide sequence is operatively linked to said nucleotide sequence encoding said O-RS; and
(III) a polycistronic operon comprising a plurality of O-tRNA gene nucleotide sequences, wherein at least one O-tRNA gene is separated from at least one adjacent O-tRNA gene by a heterologous polynucleotide linker derived from a naturally occurring polynucleotide linker from a naturally occurring tRNA operon;
(b) growing said host cell; and
(c) incorporating said unnatural amino acid at said specified position in said polypeptide during translation of said polypeptide in said host cell, thereby producing said polypeptide of interest comprising said unnatural amino acid at the specified position.

### Claim 64 (depends on 63)

The method of claim 63, wherein:
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-tRNA derived from one or more Archaea tRNA; or
said providing a nucleic acid construct comprises providing a polycistronic operon comprising a plurality of nucleotide sequences encoding one or more O-tRNA species; or
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-tRNA comprising a nucleotide sequence of SEQ ID NO: 1 (MjtRNA-Tyr(CUA)); or
said providing a nucleic acid construct comprises providing a polycistronic operon comprising a plurality of the nucleotide sequence of SEQ ID NO: 1 (MjtRNA-Tyr(CUA)).

### Claim at position 16

65-67. (canceled)

### Claim 68 (depends on 63)

The method of claim 63, wherein:
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-RS derived from a Methanococcus jannaschii aminoacyl-tRNA synthetase; or
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-RS derived from a Methanococcus jannaschii tyrosyl-tRNA synthetase; or
said providing a nucleic acid construct comprises providing a nucleotide sequence encoding an O-RS having aspartic acid to arginine substitution at amino acid position 286 or at a position analogous to position 286, relative to the amino acid sequence of wild-type Methanococcus jannaschii tyrosyl-tRNA synthetase provided in SEQ ID NO: 2 (wild type Mj-tRNATyrRS).

### Claim at position 18

69-70. (canceled)

### Claim 71 (depends on 63)

The method of claim 63, wherein:
said providing a nucleic acid construct of (I) comprises providing nucleotide sequences corresponding to an Escherichia coli proline tRNA promoter and terminator sequences, said E. coli proline tRNA selected from E. coli proK, proL and proM tRNA; or
said providing a nucleic acid construct of (I) comprises providing nucleotide sequences corresponding to an Escherichia coli proline tRNA promoter and terminator sequences, said E. coli proline tRNA promoter and terminator sequences comprising the promoter and terminator sequences of E. coli proK provided in SEQ ID NOS: 32 (promoter) and 33 (terminator), respectively.

### Claim 72

(canceled)

### Claim 73 (depends on 63)

The method of claim 63, wherein:
said providing a nucleic acid construct of (III) comprises providing a plurality of identical heterologous polynucleotide linkers; or
said providing a nucleic acid construct of (III) comprises providing a plurality of heterologous polynucleotide linkers, wherein at least two of the heterologous polynucleotide linkers are different; or
said providing a polycistronic operon of (III) comprises providing a heterologous polynucleotide linker comprising a 5′ terminal thymidine nucleotide, a 3′ terminal adenosine nucleotide, or both a 5′ terminal thymidine nucleotide and a 3′ terminal adenosine nucleotide; or
said providing a polycistronic operon of (III) comprises providing a heterologous polynucleotide linker derived from a naturally occurring polynucleotide linker located between the endogenous Escherichia coli tRNA genes selected from: valU and valX; ileT and alaT; serV and argV; valV and valW; glyT and thrT; metT and leuW; glnW and metU; hisR and leuT; glnU and glnW; leuP and leuV; glnV and glnX; alaW and alaX; ileU and alaU; ileV and alaV; metU and glnV; glyW and cysT; argX and hisR; and argY and argZ; or
said providing a polycistronic operon of (III) comprises providing a heterologous polynucleotide linker derived from the nucleotide sequence of SEQ ID NO: 14 (valU/valX linker) or 15 (ileT/alaT linker).

### Claim at position 22

74-77. (canceled)

### Claim 78 (depends on 63)

The method of claim 63, wherein:
said providing a host cell comprises providing a eubacterial host cell; or
said providing a host cell comprises providing an Escherichia coli host cell.

### Claim at position 24

-81. (canceled)

### Claim 82

A method for producing a polypeptide of interest comprising an unnatural amino acid at a specified position, the method comprising:
(a) providing a translation system, said translation system comprising:
(i) an unnatural amino acid;
(ii) a nucleic acid construct comprising a nucleotide sequence encoding an orthogonal tRNA (O-tRNA) and a nucleotide sequence encoding an orthogonal aminoacyl-tRNA synthetase (O-RS), wherein said O-RS preferentially aminoacylates said O-tRNA with said unnatural amino acid; and,
(iii) a polynucleotide encoding said polypeptide of interest, said polynucleotide comprising at least one selector codon that is recognized by said O-tRNA, and wherein the position of the selector codon correlates to the specified position of the unnatural amino acid in the polypeptide of interest;
(iv) a host cell comprising (i), (ii) and (iii); and
(b) growing said host cell; and
(c) incorporating said unnatural amino acid at said specified position in said polypeptide during translation of said polypeptide in said host cell, thereby producing said polypeptide of interest comprising said unnatural amino acid at the specified position.
